GILDER GAGNON HOWE & CO LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 177 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$341,955
-23.2%
9,592
-0.6%
0.01%
-16.7%
Q2 2023$445,062
+47.9%
9,648
+91.1%
0.01%
+20.0%
Q2 2022$301,000
-38.6%
5,048
-25.2%
0.01%0.0%
Q1 2022$490,000
-58.5%
6,751
-51.9%
0.01%
-28.6%
Q4 2021$1,180,000
-27.6%
14,034
-22.3%
0.01%
-12.5%
Q3 2021$1,629,000
-6.9%
18,060
-1.5%
0.01%
-11.1%
Q2 2021$1,749,000
-16.5%
18,344
-0.2%
0.01%
-18.2%
Q1 2021$2,094,000
-35.0%
18,388
-21.0%
0.01%
-31.2%
Q4 2020$3,223,000
+564.5%
23,284
+240.4%
0.02%
+100.0%
Q3 2016$485,000
+44.8%
6,840
-0.0%
0.01%
+14.3%
Q2 2016$335,000
-22.8%
6,842
-0.2%
0.01%
-22.2%
Q1 2016$434,0000.0%6,855
+61.9%
0.01%
+50.0%
Q2 2015$434,000
-2.5%
4,235
-40.9%
0.01%0.0%
Q1 2015$445,000
+38.6%
7,162
-2.2%
0.01%
+20.0%
Q4 2014$321,000
-25.0%
7,324
-3.2%
0.01%
-16.7%
Q3 2014$428,000
+25.5%
7,567
-0.3%
0.01%
+20.0%
Q2 2014$341,000
-65.6%
7,589
-62.6%
0.01%
-64.3%
Q1 2014$992,00020,2910.01%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2016
NameSharesValueWeighting ↓
First Light Asset Management, LLC 213,887$29,608,0002.19%
Rock Springs Capital Management LP 566,500$78,421,0001.66%
FEDERATED HERMES, INC. 4,280,528$592,554,0001.21%
AtonRa Partners 17,646$2,443,0001.20%
EMERALD MUTUAL FUND ADVISERS TRUST 218,390$30,232,0001.05%
EMERALD ADVISERS, LLC 226,875$31,406,0001.04%
Atika Capital Management LLC 89,000$12,319,0000.96%
Capital Impact Advisors, LLC 25,582$3,541,0000.87%
JGP Global Gestao de Recursos Ltda. 1,586$220,0000.83%
CAPITAL INTERNATIONAL LTD /CA/ 79,742$11,039,0000.64%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders